Adriamycin ®

Generic name: Doxorubicin
Other brand name: Rubex ®

Chemocare.com uses generic names in all descriptions of drugs. Adriamycin is a trade name for Doxorubicin. Rubex is another trade name for Doxorubicin. In some cases, health care professionals may use the trade names Adriamycin or Rubex when referring to the generic drug name Doxorubicin.

Drug type: Adriamycin is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as an "anthracycline antiobiotic." (For more detail, see "How this drug works" section below).

What Adriamycin is used for:

How Adriamycin is given:

Side effects of Adriamycin:
Important things to remember about the side effects of adriamycin:

The following side effects are common (occurring in greater than 30%) for patients taking adriamycin:

Early: (within one week after treatment begins)

Later: (within two weeks after treatment begins)

Nadir: Meaning low point, nadir is the point in time between chemotherapy cycles in which you experience low blood counts.

Onset: 7 days
Nadir: 10-14 days
Recovery: 21-28 days

The following side effects are less common (occurring in 10-29%) for patients taking adriamycin:

Early: (within one week after treatment begins)

Later: (within two weeks after treatment begins)

A serious but uncommon side effect of adriamycin can be interference with the pumping action of the heart. You can receive only up to a certain amount of adriamycin during your lifetime. This "lifetime maximum dose" may be lower if you have heart disease risk factors such as radiation to the chest, advancing age, and use of other heart-toxic drugs. Your doctor will check your heart function before you may take any adriamycin and will monitor your heart closely during your treatment. Dose-related heart problems can occur as late as 7 or 8 years after treatments have ended.

Delayed effects:
There is a slight risk of developing a blood cancer such as leukemia years after taking adriamycin. Talk to your doctor about this risk.

This list includes common and less common and important side effects for those taking adriamycin. Side effects that are very rare - occurring in less than 10 percent of patients - are not listed here. But you should always inform your health care provider if you experience any unusual symptoms.

When to contact your doctor or health care provider:

Contact your health care provider immediately, day or night, if you should experience any of the following symptoms:

The following symptoms require medical attention, but are not emergency situations. Contact your health care provider within 24 hours of noticing any of the following:

Precautions:

Self care tips:

Monitoring and Testing:

A baseline heart evaluation is recommended before starting treatment. A full blood count will be done regularly, and a heart function test will be done as your doctor prescribes. Various tests to monitor the function of other organs (such as your kidneys and liver) will also be ordered by your physician.

How Adriamycin works:

Cancerous tumors are characterized by cell division, which is no longer controlled as it is in normal tissue. "Normal" cells stop dividing when they come into contact with like cells, a mechanism known as contact inhibition. Cancerous cells lose this ability. Cancer cells no longer have the normalchecks and balances in place that control and limit cell division. The process of cell division, whether normal or cancerous cells, is through the cell cycle. The cell cycle goes from the resting phase, through active growing phases, and then to mitosis (division).

The ability of chemotherapy to kill cancer cells depends on its ability to halt cell division. Usually, the drugs work by damaging the RNA or DNA that tells the cell how to copy itself in division. If the cells are unable to divide, they die. The faster the cells are dividing, the more likely it is that chemotherapy will kill the cells, causing the tumor to shrink. They also induce cell suicide (self-death or apoptosis).

Chemotherapy drugs that affect cells only when they are dividing are called cell-cycle specific. Chemotherapy drugs that affect cells when they are at rest are called cell-cycle non-specific. The scheduling of chemotherapy is set based on the type of cells, rate at which they divide, and the time at which a given drug is likely to be effective. This is why chemotherapy is typically given in cycles.

Unfortunately, chemotherapy does not know the difference between the cancerous cells and the normal cells. Chemotherapy will kill all cells that are rapidly dividing. The "normal" cells will grow back and be healthy but in the meantime, side effects occur. The "normal" cells most commonly affected by chemotherapy are the blood cells, the cells in the mouth, stomach and bowel, and the hair follicles; resulting in low blood counts, mouth sores, nausea, diarrhea, and/or hair loss. Different drugs may affect different parts of the body.

Adriamycin is classified as an antitumor antibiotic. Antitumor antibiotics are made from natural products produced by species of the soil fungus Streptomyces. These drugs act during multiple phases of the cell cycle and are considered cell-cycle specific. There are several types of antitumor antibiotics:

Note: We strongly encourage you to talk with your health care professional about your specific medical condition and treatments. The information contained in this website is meant to be helpful and educational, but is not a substitute for medical advice.